Developer docs
API playgroundTry for free, no card

Search company profiles

Mpac Lambert

Full company profile

uuid0022fl9

Namestring
Mpac Lambert
Legal namestring
Mpac Lambert Limited
Websiteurl
lamberteng.com
Company typeenum
Private
Founded yearint
1912
Descriptiontext

Mpac Lambert Limited (trading as Lambert - Ingenious Automation) is a UK-based industrial automation company headquartered in Coventry, operating as a subsidiary of MPAC Group PLC. The company designs and builds custom and modular automation systems for complex manufacturing and high-volume production, serving three primary sectors: Medtech & Diagnostics (wearable devices, ostomy products, diagnostics equipment, needle-free glucose monitoring sensors), Healthcare & Pharma (Dry Powder Inhaler systems, powder filling, intraocular lenses, pharmaceutical packaging), and Consumer Goods (razors, baby care, diapers). Its technology stack spans the full automation lifecycle — from proof of principle and lab-scale systems through build-to-print, modular platforms, custom automation, and integrated full-line solutions — and includes core manufacturing capabilities in product handling, assembly, filling and dosing, web converting, inspection and validation, and process development.

The business model is a B2B enterprise sale of capital equipment, with revenue generated from upfront design, engineering, and delivery of custom automation systems, supplemented by recurring life cycle services (SLAs, maintenance and repairs, upgrades and modernisations, spare parts, remote services, and training). Pricing is quote-based and tailored to each customer's production requirements, with multi-year contract cadences typical. Go-to-market relies on direct enterprise field sales, industry exhibitions (e.g., Interpack 2026), and a corporate website, targeting medtech, healthcare/pharma, and consumer goods manufacturers globally.

The company has recently been divested by its parent: on 8 June 2026, MPAC Group PLC announced the sale of Mpac Lambert to Mech-i-Tronic S.p.A. for £16.0m initial cash consideration plus up to £4.0m earn-out, pending regulatory clearance in Q3 2026. Prior to the sale, Mpac Lambert recorded a £1.6m loss before tax on £2.1m net assets in FY2025. The business has also executed notable strategic moves including a January 2026 partnership with GlucoModicum to deliver a first-of-its-kind automated manufacturing line for the Sofio needle-free glucose monitoring sensor, and a 2025 Red Dot Design Award for the Mpac Horizon automation system.

Short descriptiontext

Mpac Lambert Limited is a UK-based custom and modular industrial automation provider headquartered in Coventry, designing and building high-precision manufacturing systems for Medtech & Diagnostics, Healthcare & Pharma, and Consumer Goods manufacturers globally. The company is being divested by parent MPAC Group PLC to Mech-i-Tronic S.p.A. for up to £20m.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersTadcaster, United Kingdom
HQ citystring
Tadcaster
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
custom automation systems, manufacturing automation solutions, modular production platforms, medical device automation, pharmaceutical packaging machinery
Industry2 codes
PRIMARYIMAHAOAN
End-of-Line Integration & Packaging Line Systems
SECONDARYIMAHAOAK
Conveying, Feeding & Accumulation Systems (Packaging Lines)
NAICS code2 codes
  • Commercial and Service Industry Machinery Manufacturing333310
  • Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables334513
SIC code2 codes
  • Special Industry Machinery (No Metalworking Machinery)3550
  • Services-Computer Integrated Systems Design7373
Product category
Industrial Automation Systems
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Custom Automation Systems
TypeOne Time License
Description

Design and build of custom and modular automation systems for complex manufacturing and high-volume production across medtech, healthcare/pharma, and consumer goods sectors. Revenue generated from upfront system design, engineering, and manufacturing delivery.

mpac-lambert.com
2Life Cycle Services
TypeProfessional Services
Description

Ongoing revenue from service level agreements, maintenance and repairs, upgrades and modernisations, spare parts, remote services, and training throughout the automation system lifecycle.

mpac-lambert.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1Custom Solution Pricing
ModelOtherBilling cadenceMulti-year contract
Notes

Each automation solution is custom-designed and priced based on specific customer requirements, production capacity needs, and system complexity. Contact-based quoting process.

mpac-lambert.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Mpac Lambert designs and builds custom and modular automation systems for complex manufacturing and high-volume production across the medtech, healthcare/pharma, and consumer goods sectors. Its offering spans the full automation lifecycle, from proof-of-principle and lab-scale work through build-to-print, modular platforms, custom automation, and integrated full-line solutions, complemented by ongoing life cycle services including SLAs, upgrades, maintenance, spare parts, remote services, and training.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 21 million units per year initial production capacity for medical devices, expandable through modular additions
Product overview1 text field

Mpac Lambert is an automation company offering a comprehensive suite of solutions spanning the entire product lifecycle — from Proof of Principle & Concept and Lab-Scale Solutions through to Build to Print, Modular Platforms, Custom Automation, and Integrated Full Line Solutions. The portfolio includes core manufacturing capabilities (Product Handling, Product Assembly, Filling & Dosing, Web Converting, Inspection & Validation, and Innovations & Process Development), sector-specific automation for Medtech & Diagnostics, Healthcare & Pharma, and Consumer Goods, and life cycle services (Service Level Agreements, Upgrades & Modernisations, Maintenance & Repairs, Spare Parts, Remote Services, and Training). The company recently delivered a scalable automated manufacturing line for Sofio, a needle-free glucose monitoring sensor developed in partnership with GlucoModicum. Mpac Lambert is a subsidiary of MPAC Group PLC, which recently sold the company to Mech-i-Tronic S.p.A. for £16.0m cash consideration.

Product and service10 records
1Custom Automation
CategoryAutomation solution
Description

Fully customized automation systems designed and built to specific customer manufacturing requirements, processes, and product specifications, for medtech, healthcare/pharma, and consumer goods manufacturers.

2Modular Platforms
CategoryAutomation solution
Description

Scalable automation platforms built on a modular architecture that customers can expand or reconfigure over time as production volumes and product requirements evolve.

3Build to Print Automation
CategoryAutomation solution
Description

Custom manufacturing automation built to precise customer-supplied specifications and technical drawings.

4Lab-Scale Automation
CategoryAutomation solution
Description

Scaled-down automation systems designed for laboratory and early-stage clinical trial production environments.

5Proof of Principle & Concept Automation
CategoryAutomation solution
Description

Early-stage automation solutions that help customers validate and prove manufacturing concepts before committing to full-scale production deployment.

6Integrated Full Line Solutions
CategoryAutomation solution
Description

Complete end-to-end automated production lines that integrate multiple manufacturing processes (handling, assembly, filling/dosing, inspection) into a unified system.

7Life Cycle Services
CategoryAfter-sales service
Description

Ongoing post-installation services for installed automation systems, including Service Level Agreements, upgrades and modernisations, maintenance and repairs, spare parts, remote diagnostic services, and customer training.

8Medtech & Diagnostics Automation
CategorySector automation solution
Description

Sector-focussed automation solutions for medical technology and diagnostic device manufacturers, covering wearable devices, ostomy products, and diagnostic equipment.

9Healthcare & Pharma Automation
CategorySector automation solution
Description

Sector-focussed automation for healthcare and pharmaceutical applications, including Dry Powder Inhaler (DPI) systems, powder filling systems, and intraocular lens (IOL) production.

10Consumer Goods Automation
CategorySector automation solution
Description

High-volume automation for consumer goods manufacturers, covering personal care products such as razors, baby care items, and diapers.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-01-29
Description

Mpac Lambert partnered with Finnish health tech company GlucoModicum to design and build a first-of-its-kind automated manufacturing line for Sofio, a needle-free glucose monitoring sensor using magnetohydrodynamic technology. The production system achieves sub-second cycle times with initial capacity of 21 million units per year, expandable through additional modules. The collaboration spent two years conducting industrial-scale proof-of-principle work before construction, producing tens of thousands of pilot units to validate the manufacturing platform ahead of global commercial rollout.

Recent move4 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Global packaging and bottling line integrator with significant pharmaceutical/food/cosmetics exposure - directly comparable on full-line integration, modular platforms, and lifecycle services for high-volume production.

TypeDirect peer
Description

Italian-headquartered global leader in packaging machinery for pharmaceutical, cosmetics, and food industries - directly competes with Mpac Lambert in custom automation, filling/dosing, and full-line solutions for regulated customers.

TypeBroad incumbent
Description

Global industrial automation solutions provider with life sciences and complex manufacturing capabilities - broader incumbent offering comparable custom automation to Mpac Lambert's medtech and consumer goods customers.

TypeBroad incumbent
Description

Large industrial process technology provider with significant pharmaceutical and food automation capabilities - broader incumbent with overlapping custom-engineering and modular automation offerings.

TypeDirect peer
Description

Italian packaging machinery manufacturer specialising in pharmaceuticals and cosmetics - overlapping strongly with Mpac Lambert across product handling, filling/dosing, and integrated line solutions.

TypeDirect peer
Description

Formerly Bosch Packaging Technology, Syntegon is a leading global provider of packaging and processing machinery for the pharmaceutical and medical device industries - directly comparable to Mpac Lambert's medtech and pharma vertical automation offering.

TypeBroad incumbent
Description

Diversified technology group with a substantial packaging machinery business (formerly Körber Packaging) in pharma and consumer - broader incumbent offering overlapping capability to Mpac Lambert's automation portfolio.

TypeDirect peer
Description

Italian supplier of pharmaceutical glass containers and integrated medical device manufacturing equipment - serving overlapping medtech and pharma customers with comparable precision automation capabilities.

TypeDirect peer
Description

German packaging machinery manufacturer focused on pharmaceuticals, medical devices, and consumer goods - directly competitive on custom filling, assembly, and modular automation platforms for the same verticals as Mpac Lambert.

TypeDirect peer
Description

German specialist in pharmaceutical and medical device assembly and packaging machinery - directly comparable on custom automation, precision assembly, and lifecycle service offerings for similar end markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Mpac Lambert

Industrial Automation Systemslamberteng.com

Mpac Lambert Limited is a UK-based custom and modular industrial automation provider headquartered in Coventry, designing and building high-precision manufacturing systems for Medtech & Diagnostics, Healthcare & Pharma, and Consumer Goods manufacturers globally. The company is being divested by parent MPAC Group PLC to Mech-i-Tronic S.p.A. for up to £20m.

What Mpac Lambert does

Mpac Lambert Limited (trading as Lambert - Ingenious Automation) is a UK-based industrial automation company headquartered in Coventry, operating as a subsidiary of MPAC Group PLC. The company designs and builds custom and modular automation systems for complex manufacturing and high-volume production, serving three primary sectors: Medtech & Diagnostics (wearable devices, ostomy products, diagnostics equipment, needle-free glucose monitoring sensors), Healthcare & Pharma (Dry Powder Inhaler systems, powder filling, intraocular lenses, pharmaceutical packaging), and Consumer Goods (razors, baby care, diapers). Its technology stack spans the full automation lifecycle — from proof of principle and lab-scale systems through build-to-print, modular platforms, custom automation, and integrated full-line solutions — and includes core manufacturing capabilities in product handling, assembly, filling and dosing, web converting, inspection and validation, and process development.

The business model is a B2B enterprise sale of capital equipment, with revenue generated from upfront design, engineering, and delivery of custom automation systems, supplemented by recurring life cycle services (SLAs, maintenance and repairs, upgrades and modernisations, spare parts, remote services, and training). Pricing is quote-based and tailored to each customer's production requirements, with multi-year contract cadences typical. Go-to-market relies on direct enterprise field sales, industry exhibitions (e.g., Interpack 2026), and a corporate website, targeting medtech, healthcare/pharma, and consumer goods manufacturers globally.

The company has recently been divested by its parent: on 8 June 2026, MPAC Group PLC announced the sale of Mpac Lambert to Mech-i-Tronic S.p.A. for £16.0m initial cash consideration plus up to £4.0m earn-out, pending regulatory clearance in Q3 2026. Prior to the sale, Mpac Lambert recorded a £1.6m loss before tax on £2.1m net assets in FY2025. The business has also executed notable strategic moves including a January 2026 partnership with GlucoModicum to deliver a first-of-its-kind automated manufacturing line for the Sofio needle-free glucose monitoring sensor, and a 2025 Red Dot Design Award for the Mpac Horizon automation system.

Mpac Lambert firmographics

Firmographics
Name
Mpac Lambert
Legal name
Mpac Lambert Limited
Website
https://lamberteng.com
Company type
Private
Founded year
1912
Operating status
Acquired
Headcount range
101–250 employees
Short description
Mpac Lambert Limited is a UK-based custom and modular industrial automation provider headquartered in Coventry, designing and building high-precision manufacturing systems for Medtech & Diagnostics, Healthcare & Pharma, and Consumer Goods manufacturers globally. The company is being divested by parent MPAC Group PLC to Mech-i-Tronic S.p.A. for up to £20m.
Ownership category
akta.pro rank

Mpac Lambert industry classification

Industry
Product category
Industrial Automation Systems
NAICS
Commercial and Service Industry Machinery Manufacturing (333310), Instruments and Related Products Manufacturing for Measuring, Displaying, and Controlling Industrial Process Variables (334513)
SIC
Special Industry Machinery (No Metalworking Machinery) (3550), Services-Computer Integrated Systems Design (7373)
akta.pro industry
PRIMARYIMAHAOAN
End-of-Line Integration & Packaging Line Systems
SECONDARYIMAHAOAK
Conveying, Feeding & Accumulation Systems (Packaging Lines)

Keywords

  • Custom automation systems
  • Manufacturing automation solutions
  • Modular production platforms
  • Medical device automation
  • Pharmaceutical packaging machinery

Where Mpac Lambert is headquartered

Location

Headquarters

HQ city
Tadcaster
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Mpac Lambert business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Custom Automation Systems: Design and build of custom and modular automation systems for complex manufacturing and high-volume production across medtech, healthcare/pharma, and consumer goods sectors. Revenue generated from upfront system design, engineering, and manufacturing delivery.
  2. Life Cycle Services: Ongoing revenue from service level agreements, maintenance and repairs, upgrades and modernisations, spare parts, remote services, and training throughout the automation system lifecycle.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom Solution Pricing

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Mpac Lambert product offering

Product offering

Core offering

Mpac Lambert designs and builds custom and modular automation systems for complex manufacturing and high-volume production across the medtech, healthcare/pharma, and consumer goods sectors. Its offering spans the full automation lifecycle, from proof-of-principle and lab-scale work through build-to-print, modular platforms, custom automation, and integrated full-line solutions, complemented by ongoing life cycle services including SLAs, upgrades, maintenance, spare parts, remote services, and training.

Product overview

Mpac Lambert is an automation company offering a comprehensive suite of solutions spanning the entire product lifecycle — from Proof of Principle & Concept and Lab-Scale Solutions through to Build to Print, Modular Platforms, Custom Automation, and Integrated Full Line Solutions. The portfolio includes core manufacturing capabilities (Product Handling, Product Assembly, Filling & Dosing, Web Converting, Inspection & Validation, and Innovations & Process Development), sector-specific automation for Medtech & Diagnostics, Healthcare & Pharma, and Consumer Goods, and life cycle services (Service Level Agreements, Upgrades & Modernisations, Maintenance & Repairs, Spare Parts, Remote Services, and Training). The company recently delivered a scalable automated manufacturing line for Sofio, a needle-free glucose monitoring sensor developed in partnership with GlucoModicum. Mpac Lambert is a subsidiary of MPAC Group PLC, which recently sold the company to Mech-i-Tronic S.p.A. for £16.0m cash consideration.

Differentiator

Problem solved

Functional benefit

Products and services

  • Custom Automation Fully customized automation systems designed and built to specific customer manufacturing requirements, processes, and product specifications, for medtech, healthcare/pharma, and consumer goods manufacturers.
  • Modular Platforms Scalable automation platforms built on a modular architecture that customers can expand or reconfigure over time as production volumes and product requirements evolve.
  • Build to Print Automation Custom manufacturing automation built to precise customer-supplied specifications and technical drawings.
  • Lab-Scale Automation Scaled-down automation systems designed for laboratory and early-stage clinical trial production environments.
  • Proof of Principle & Concept Automation Early-stage automation solutions that help customers validate and prove manufacturing concepts before committing to full-scale production deployment.
  • Integrated Full Line Solutions Complete end-to-end automated production lines that integrate multiple manufacturing processes (handling, assembly, filling/dosing, inspection) into a unified system.
  • Life Cycle Services Ongoing post-installation services for installed automation systems, including Service Level Agreements, upgrades and modernisations, maintenance and repairs, spare parts, remote diagnostic services, and customer training.
  • Medtech & Diagnostics Automation Sector-focussed automation solutions for medical technology and diagnostic device manufacturers, covering wearable devices, ostomy products, and diagnostic equipment.
  • Healthcare & Pharma Automation Sector-focussed automation for healthcare and pharmaceutical applications, including Dry Powder Inhaler (DPI) systems, powder filling systems, and intraocular lens (IOL) production.
  • Consumer Goods Automation High-volume automation for consumer goods manufacturers, covering personal care products such as razors, baby care items, and diapers.

Quantifiable outcome

  • 21 million units per year initial production capacity for medical devices, expandable through modular additions

Companies that use Mpac Lambert

Customer profile

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Mpac Lambert technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Mpac Lambert partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • GlucoModicumcoreStrategic or Co-development Partner · 29 January 2026Mpac Lambert partnered with Finnish health tech company GlucoModicum to design and build a first-of-its-kind automated manufacturing line for Sofio, a needle-free glucose monitoring sensor using magnetohydrodynamic technology. The production system achieves sub-second cycle times with initial capacity of 21 million units per year, expandable through additional modules. The collaboration spent two years conducting industrial-scale proof-of-principle work before construction, producing tens of thousands of pilot units to validate the manufacturing platform ahead of global commercial rollout.

Scale indicators4 records

Recent moves4 records

Expansion highlights4 records

Mpac Lambert competitors and assessment

Company assessment

Direct peers

  • Krones AG: Global packaging and bottling line integrator with significant pharmaceutical/food/cosmetics exposure - directly comparable on full-line integration, modular platforms, and lifecycle services for high-volume production.
  • IMA Group: Italian-headquartered global leader in packaging machinery for pharmaceutical, cosmetics, and food industries - directly competes with Mpac Lambert in custom automation, filling/dosing, and full-line solutions for regulated customers.
  • Marchesini Group: Italian packaging machinery manufacturer specialising in pharmaceuticals and cosmetics - overlapping strongly with Mpac Lambert across product handling, filling/dosing, and integrated line solutions.
  • Syntegon Technology: Formerly Bosch Packaging Technology, Syntegon is a leading global provider of packaging and processing machinery for the pharmaceutical and medical device industries - directly comparable to Mpac Lambert's medtech and pharma vertical automation offering.
  • Stevanato Group: Italian supplier of pharmaceutical glass containers and integrated medical device manufacturing equipment - serving overlapping medtech and pharma customers with comparable precision automation capabilities.
  • Optima Group: German packaging machinery manufacturer focused on pharmaceuticals, medical devices, and consumer goods - directly competitive on custom filling, assembly, and modular automation platforms for the same verticals as Mpac Lambert.
  • Harro Höfliger: German specialist in pharmaceutical and medical device assembly and packaging machinery - directly comparable on custom automation, precision assembly, and lifecycle service offerings for similar end markets.

Broad incumbents

  • ATS Corporation: Global industrial automation solutions provider with life sciences and complex manufacturing capabilities - broader incumbent offering comparable custom automation to Mpac Lambert's medtech and consumer goods customers.
  • GEA Group: Large industrial process technology provider with significant pharmaceutical and food automation capabilities - broader incumbent with overlapping custom-engineering and modular automation offerings.
  • Körber: Diversified technology group with a substantial packaging machinery business (formerly Körber Packaging) in pharma and consumer - broader incumbent offering overlapping capability to Mpac Lambert's automation portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

Mpac Lambert financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Mpac Lambert leadership team

Management profile

Number of profiles

Profiles3 records

Mpac Lambert funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Mpac Lambert M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Mpac Lambert

What does Mpac Lambert do?

Mpac Lambert designs and builds custom and modular automation systems for complex manufacturing and high-volume production across the medtech, healthcare/pharma, and consumer goods sectors. Its offering spans the full automation lifecycle, from proof-of-principle and lab-scale work through build-to-print, modular platforms, custom automation, and integrated full-line solutions, complemented by ongoing life cycle services including SLAs, upgrades, maintenance, spare parts, remote services, and training.

Is Mpac Lambert a public or private company?

Mpac Lambert is a private company. It is classified as corporate owned and is currently acquired.

When was Mpac Lambert founded?

Mpac Lambert was founded in 1912. It employs 101 to 250 people.

Where is Mpac Lambert based?

Mpac Lambert is headquartered in Tadcaster, United Kingdom, in the Europe region.

How does Mpac Lambert make money?

Two revenue lines are on record. Custom Automation Systems are the primary driver. The others are life Cycle Services.

Who are Mpac Lambert's main competitors?

Direct peers on record are Krones AG, IMA Group, Marchesini Group, Syntegon Technology, Stevanato Group, Optima Group and Harro Höfliger. Broad incumbents are ATS Corporation, GEA Group and Körber.

Does Mpac Lambert have an API?

No public API is recorded for Mpac Lambert.

What industry is Mpac Lambert in?

Mpac Lambert's product category is Industrial Automation Systems. Its primary akta.pro industry code is IMAHAOAN, End-of-Line Integration & Packaging Line Systems, with a secondary code of IMAHAOAK, Conveying, Feeding & Accumulation Systems (Packaging Lines). Its NAICS code is 333310 and its SIC code is 3550.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The UKCoventry automation group completes division sale to Italian firmCoventry-headquartered packaging and automation group Mpac has completed the sale of its Mpac Lambert Limited division to Italian firm Mech.i.Tronic S.p.A, a transaction first announced in June 2024. The deal involved initial cash consideration of £16 million with potential earn-out of up to £4 million contingent on Lambert's 2026 financial performance. Proceeds from the sale deliver a significant reduction in net debt for Mpac and align the group toward scalable, full-line packaging machinery solutions, according to CEO Adam Holland.Investing.comWhy is MPAC stock collapsing today? By Investing.comMPAC Group PLC stock collapsed 13.1% to 228p on Tuesday after issuing a damaging profit warning, with the board expecting FY 2026 underlying profit before tax to be substantially below market expectations on a like-for-like basis. The company simultaneously announced the sale of its loss-making Mpac Lambert Limited subsidiary to Mech-i-Tronic S.p.A. for an initial £16.0m cash consideration, with regulatory clearance expected in Q3 — a disposal that analysts view as balance-sheet repair rather than a strategic premium exit, given Lambert generated a £1.6m loss before tax on just £2.1m net assets in FY 2025.Hattiesburg AmericanMpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring SensorMpac Lambert has partnered with GlucoModicum to design and build a first-of-its-kind automated manufacturing line for Sofio, GlucoModicum's needle-free glucose monitoring sensor. The production system achieves sub-second cycle times with an initial capacity of 21 million units per year and can be expanded by adding additional modules. The collaboration aims to transition Sofio from lab-scale demonstration to commercial production for global distribution, making needle-free glucose tracking more widely accessible.The News StarMpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring SensorMpac Lambert has partnered with GlucoModicum to design and build a first-of-its-kind automated manufacturing line for Sofio, a needle-free glucose monitoring sensor. The production system achieves sub-second cycle times with an initial capacity of approximately 21 million units per year, expandable through additional modules. The collaboration enables GlucoModicum to scale from lab-scale demonstration to commercial production for global distribution of the MHD-based monitoring device.The Desert SunMpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring SensorMpac Lambert has partnered with GlucoModicum to design and build an automated manufacturing line for Sofio, a needle-free glucose monitoring sensor that uses magnetohydrodynamic technology to measure glucose levels without needles. The production system achieves sub-second cycle times and maintains medical-grade precision while delivering an initial annual capacity of approximately 21 million units, with options to expand further. The two companies spent two years conducting industrial-scale proof-of-principle work before construction, producing tens of thousands of pilot units to validate the manufacturing platform ahead of global commercial rollout.Weekly VoiceMpac Lambert Partners with GlucoModicum to Deliver Scalable Automation for Needle-Free Glucose Monitoring SensorMpac Lambert has partnered with GlucoModicum to design and build a first-of-its-kind automated manufacturing line for Sofio, a needle-free glucose monitoring sensor using magnetohydrodynamic technology. The production system achieves sub-second cycle time with an initial capacity of approximately 21 million units annually, expandable through additional modules. The collaboration enables GlucoModicum to transition Sofio from lab-scale manual and semi-automated production to high-volume commercial manufacturing for global distribution.